国产康多机器人对比达芬奇Xi用于机器人辅助远端胰腺切除术的短期结局:两中心前瞻性队列研究
结果显示两组手术成功、中转、保脾及90天死亡率无显著差异,康多组住院费用显著更低,但NASA-TLX评分提示体力需求、努力及总负荷较高(差异不显著)。
要点
- 康多机器人系统-2000在机器人辅助远端胰腺切除术中疗效与安全性不劣于达芬奇Xi。
- 康多组住院费用显著低于达芬奇Xi组($8131.6 vs $9859.6,P<0.001)。
- 康多组NASA-TLX评分体力需求、努力及总负荷较高但差异无统计学意义(均P>0.05)。
核心结论
- 康多机器人系统-2000在机器人辅助远端胰腺切除术中展现出与达芬奇Xi相当的疗效和安全性。
- 康多系统在人机工学设计上仍需进一步改进,但在手术成本方面具有显著优势,可作为达芬奇Xi的可行替代方案。
研究设计与样本
- 非随机、非盲法分组:康多机器人系统-2000组(n=33)和达芬奇Xi组(n=50)。
- 前瞻性收集基线人口学、围手术期参数、术后并发症、人机工效学及住院费用并进行组间比较。
主要发现
- 基线特征均衡。
- 达芬奇Xi组1例因严重粘连和脾静脉出血中转开腹。
- 手术成功、中转、保脾及90天死亡率组间均无显著差异(均P>0.05)。
- NASA-TLX评分显示康多组体力需求、努力及总负荷较高,但差异均无统计学意义(均P>0.05)。
- 主要并发症(Clavien-Dindo≥III级)及特定并发症组间无显著差异;术中失血量、手术时间及术后住院时间无显著差异。
临床怎么用
- 在机器人辅助远端胰腺切除术中,康多机器人系统-2000可作为达芬奇Xi的可行替代方案,尤其适用于关注手术成本的场景。
- 选择康多系统时需考虑其人机工效学设计可能增加术者体力需求与工作负荷,尚需进一步改进。
局限性
- 本研究为初步前瞻性观察性研究,样本量有限(康多组33例,达芬奇Xi组50例)。
- 非随机、非盲法设计可能引入选择偏倚。
- 随访时间限于短期结局,缺乏长期肿瘤学结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Robotic surgery is a transformative approach for abdominal tumors. With the emergence of multiple robotic systems, evidence on their comparative oncological outcomes remains limited. This two-center prospective observational cohort study aimed to compare surgical efficacy and short-term oncological outcomes between the novel KangDuo Surgical Robot System-2000 (KD-SR-2000) and the Da Vinci Xi system in robot-assisted distal pancreatectomy (RDP). METHODS: This two-center prospective observational cohort study enrolled patients with pancreatic tumors who scheduled for RDP at Peking Union Medical College Hospital and Peking University First Hospital between December 2023 and May 2025. Eligible patients were assigned into either the KD-SR-2000 group (n = 33) or the Da Vinci Xi group (n = 50) in a non-randomized, non-blinded manner. Baseline demographics, perioperative parameters, postoperative complications, ergonomics, and hospitalization costs were prospectively collected and compared between groups. RESULTS: Baseline characteristics were balanced. One case in the Da Vinci Xi group was converted to laparotomy due to severe adhesions and splenic vein bleeding. No significant differences were observed in surgical success, conversion, spleen preservation, or 90-day mortality rates (all P > 0.05). NASA-TLX scores indicated higher physical demand, effort, and total workload in the KD-SR-2000 group, though differences were not significant (all P > 0.05). Major complications (Clavien-Dindo ≥ III) and specific complications showed no significant differences. The KD-SR-2000 group had significantly lower hospitalization costs ($8131.6 [7642.4-9960.7] vs. $9859.6 [9022.4-18,965.8], P < 0.001). Intraoperative blood loss, operation time, and postoperative stay did not differ significantly. CONCLUSIONS: In this preliminary prospective observational study, the KD-SR-2000 system demonstrated comparable efficacy and safety to the Da Vinci Xi in the RDP procedure. While further improvements are needed in its ergonomic design, it possesses significant advantages in surgical costs and may be considered a viable alternative to the Da Vinci Xi system.
引用
- Weng G, Cao Z, Ma Y, et al. Short-term outcomes of robotic-assisted distal pancreatectomy using domestic KangDuo Surgical Robot-2000 System versus Da Vinci Xi system: a two-center prospective observational cohort study. Surg Endosc. 2026. PMID: 42637946. doi:10.1007/s00464-026-13157-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。